Boston, Massachusetts, United States
Contact Info
1K followers
500+ connections
Boston, Massachusetts, United States
Contact Info
1K followers
500+ connections
Activity
-
In the past year, Jenny Hamilton led Azalea Therapeutics from launch to 14 employees. Happy birthday Azalea! 🎂 🎉 Spun off from Jennifer Doudna's…
In the past year, Jenny Hamilton led Azalea Therapeutics from launch to 14 employees. Happy birthday Azalea! 🎂 🎉 Spun off from Jennifer Doudna's…
Liked by Linda T. Vo, PhD
-
An honor and a privilege, and very well deserved! Dr. Sankaran has made great strides in understanding the complexities of blood formation. As a…
An honor and a privilege, and very well deserved! Dr. Sankaran has made great strides in understanding the complexities of blood formation. As a…
Liked by Linda T. Vo, PhD
-
I am honored to join the board of the National Brain Tumor Society. As a survivor and advocate, I am looking forward to working with the society to…
I am honored to join the board of the National Brain Tumor Society. As a survivor and advocate, I am looking forward to working with the society to…
Liked by Linda T. Vo, PhD
Experience & Education
Publications
-
Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs
Molecular Therapy
-
Treg cell-based therapies: challenges and perspectives
Nature Reviews Immunology
-
A systems biology pipeline identifies regulatory networks for stem cell engineering.
Nature Biotechnology
-
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors.
Science Translational Medicine
-
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.
Proceedings of the National Academy of Sciences
Honors & Awards
-
Damon Runyon Postdoctoral Research Fellowship
Damon Runyon Cancer Research Foundation
-
HHMI Hanna Gray Fellow Finalist
Howard Hughes Medical Institute
-
UCSF Sandler Fellow Finalist
UCSF
-
Albert J. Ryan Fellowship
Albert J. Ryan Foundation
-
NSF Graduate Research Fellowship
National Science Foundation (NSF)
-
Ronald E. McNair Scholarship
UC Berkeley
-
Cal Independent Scholar (Berkeley Hope Scholar)
UC Berkeley
-
Regents' and Chancellor's Scholarship
UC Berkeley
More activity by Linda T.
-
Abata co-founder and advisor Richard Ransohoff on the need in Progressive MS and ABA-101’s potential. ABA-101 may significantly benefit patients with…
Abata co-founder and advisor Richard Ransohoff on the need in Progressive MS and ABA-101’s potential. ABA-101 may significantly benefit patients with…
Liked by Linda T. Vo, PhD
-
Abata CEO Samantha Singer comments on the IND clearance of ABA-101, which validates our approach to leveraging Tregs to treat autoimmune diseases…
Abata CEO Samantha Singer comments on the IND clearance of ABA-101, which validates our approach to leveraging Tregs to treat autoimmune diseases…
Liked by Linda T. Vo, PhD
-
Proud of the team that got us to this milestone and eager to get to the next!
Proud of the team that got us to this milestone and eager to get to the next!
Liked by Linda T. Vo, PhD
-
We’re excited to announce IND clearance of ABA-101 for Progressive Multiple Sclerosis (MS). It’s the first open IND for our best-in-class autologous…
We’re excited to announce IND clearance of ABA-101 for Progressive Multiple Sclerosis (MS). It’s the first open IND for our best-in-class autologous…
Liked by Linda T. Vo, PhD
-
Justin Eyquem, an affiliate investigator at Gladstone Institutes and assistant professor of medicine in the Division of Hematology and Oncology at UC…
Justin Eyquem, an affiliate investigator at Gladstone Institutes and assistant professor of medicine in the Division of Hematology and Oncology at UC…
Liked by Linda T. Vo, PhD
-
Our paper describing a gene regulatory model of a normal, full-term human placenta was published yesterday in Science Advances! Led by Dr. Alison…
Our paper describing a gene regulatory model of a normal, full-term human placenta was published yesterday in Science Advances! Led by Dr. Alison…
Liked by Linda T. Vo, PhD
-
SFBN Feed: Marea Therapeutics raises $190M in debut, targeting overlooked ANGPTL4 in cardiometabolics https://lnkd.in/gY9Bc2if A Third Rock…
SFBN Feed: Marea Therapeutics raises $190M in debut, targeting overlooked ANGPTL4 in cardiometabolics https://lnkd.in/gY9Bc2if A Third Rock…
Liked by Linda T. Vo, PhD
-
I'm excited to share that I have recently started as a Senior Advisor at the newly established U.S. Artificial Intelligence Safety Institute (AISI)…
I'm excited to share that I have recently started as a Senior Advisor at the newly established U.S. Artificial Intelligence Safety Institute (AISI)…
Liked by Linda T. Vo, PhD
-
It’s hard to believe that after three+ years of service, my tour at the White House Office of Science and Technology Policy has come to an end. It…
It’s hard to believe that after three+ years of service, my tour at the White House Office of Science and Technology Policy has come to an end. It…
Liked by Linda T. Vo, PhD
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More